NCT03742258 2025-06-18Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell LymphomaNorthwestern UniversityPhase 1 Completed12 enrolled 13 charts
NCT02541565 2020-10-14Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular LymphomaUniversity of WashingtonPhase 1 Completed30 enrolled 9 charts